Featured Post from Michigan State University

Ask the Expert: Vaccine myths and scientific facts

Mar 18, 2021

7 min

Peter Gulick, DO FACP, FIDSA, FACOI


Now that there are authorized and recommended COVID-19 vaccines, it is critical people receive accurate information. Peter Gulick, professor of medicine at the Michigan State University College of Osteopathic Medicine and infectious disease expert, reviews some myths about the vaccine and counters these with scientific facts.



Myth: The COVID-19 vaccines were developed in a rush, so their effectiveness and safety can’t be trusted.



Fact: Studies found that the Pfizer/BioNTech and Moderna are both about 95% effective compared to the influenza vaccine, which ranges from being 50% to 60% effective each year. The Johnson & Johnson vaccine is 85% effective at curbing serious or moderate illness. The most important statistic is that all three were 100% effective in stopping hospitalizations and death.


As of March 9, 2021, the Centers for Disease Control and Prevention reports that 93.7 million people have been vaccinated and all safety data collected from these doses show no red flags. There have been about 5 cases of anaphylaxis, an allergic reaction, per 1 million but this is no different than allergic reactions from other vaccines.


There are many reasons why the COVID-19 vaccines could be developed so quickly and here are a few:


The COVID-19 vaccines from Pfizer/BioNTech and Moderna were created with a messenger RNA technology that has been in development for years, so the companies could start the vaccine development process early in the pandemic.

China isolated and shared genetic information about COVID-19 promptly so scientists could start working on vaccines.


The vaccine developers didn’t skip any testing steps but conducted some of the steps on an overlapping schedule to gather data faster.

The Pfizer/BioNTech and Moderna vaccines were created using messenger RNA, or mRNA, which allows a faster approach than the traditional way that vaccines are made.


Because COVID-19 is so contagious and widespread, it did not take long to see if the vaccine worked for the vaccinated study volunteers.


Companies began making vaccines early in the process — even before FDA authorization — so some supplies were ready when authorization occurred.

They develop COVID-19 vaccines so quickly also due to years of previous research on the SARS COV-1, a related virus.



Myth: The messenger RNA technology used to make the Pfizer/BioNTech and Moderna COVID-19 vaccine is brand new.



Fact: The messenger RNA technology behind these two vaccines has been studied and in development for almost two decades. Interest has grown in these vaccines because they can be developed in a laboratory using readily available materials, making vaccine development faster. mRNA vaccines have been studied before for flu, Zika and rabies.





Myth: You only need one dose of J&J vaccine so it’s more effective.



Fact: Johnson & Johnson’s vaccine uses a different strategy — a weakened cold virus that is reprogrammed to include the code for the spike protein. Once inside the body, the viral genes trigger a similar response against the virus. All three vaccines are considered overall effective and 100% effective in preventing hospitalizations and death.




Myth: Vaccine efficacy and effectiveness mean the same thing.



Fact: Efficacy and effectiveness do not mean the same thing. “Efficacy” refers to the results for how well a drug or vaccine works based on testing while “effectiveness” refers to how well these products work in the real world, in a much larger group of people. Most people, however, use them interchangeably even though they have different scientific meanings.


Myth: The vaccines aren’t effective against new strains of the virus.



Fact: Currently, we know both the U.K. strain as well as the South African variant have increased transmissibility of 30% to 50% over the natural strain. As far as an increase in causing more serious disease, it is not known yet. We have over 600 U.K. variants in Michigan and one case of the South African variant, and I just heard of 47 cases of the U.K. variant in Grand Ledge. We (Michigan) are second in the nation in variants, but that's likely because we test for them more.


The most important information is that the vaccines, in general, are 100% effective in prevention of hospitalization and death. So, it is felt they all offer some protection against variants to prevent serious disease.


As far as the Johnson & Johnson, it was used with variants and has efficacy overall of 72% in U.S., 66% in Latin America and 57% in South Africa (where the main strain is the South African variant). All companies are looking at modifying (their products) (the mRNA) to cover variants and either give a booster or a multivalent vaccine to cover all variants.


Myth: There are severe side effects of the COVID-19 vaccines.


Fact: The COVID-19 vaccine can have side effects, but the vast majority go away quickly and aren’t serious. The vaccine developers report that some people experience pain where they were injected; body aches; headaches or fever, lasting for a day or two. This is good and are signs that the vaccine is working to stimulate your immune system. If symptoms persist beyond two days, you should call your doctor.


Myth: Getting the COVID-19 vaccine gives you COVID-19.


Fact: The vaccine for COVID-19 cannot and will not give you COVID-19. The two authorized mRNA vaccines instruct your cells to reproduce a protein that is part of the SARS-CoV-2 coronavirus, which helps your body recognize and fight the virus, if it comes along. The COVID-19 vaccine does not contain the SARS-Co-2 virus, so you cannot get COVID-19 from the vaccine.


The Johnson & Johnson vaccine was developed using adenovirus vector technology and also will not give you COVID-19. It shows your immune system a weakened, common cold virus “disguised” as the coronavirus instead. Adenovirus vaccines have been around for about two decades, the same as mRNA vaccines. Johnson & Johnson developed a vaccine for Ebola using this technology.


Myth: The vaccines are ineffective against the virus variants.


Fact: More time is needed to study the vaccines’ effectiveness against the variants. Studies are now being conducted to determine if a booster dose is needed to protect against the variants or if modifications to the vaccines are needed.


Myth: I already had COVID-19 and I have recovered, so I don't need to get the vaccine.


Fact: There is not enough information currently available to say if or for how long after getting COVID-19 someone is protected from getting it again. This is called natural immunity. Early evidence suggests natural immunity from COVID-19 may not last very long, but more studies are needed to better understand this. The CDC recommends getting the COVID-19 vaccine, even if you’ve had COVID-19 previously. However, those that had COVID-19 should delay getting the vaccination until about 90 days from diagnosis. People should not get vaccinated if in quarantine after exposure or if they have COVID-19 symptoms.


Myth: I won't need to wear a mask after I get the vaccine.



Fact: It may take time for everyone who wants a COVID-19 vaccination to get one. Also, while the vaccine may prevent you from getting sick, more research is needed, but early indications show that while the vaccine is effective in reducing transmission, it is possible for a vaccinated person to spread the virus. Until more is understood about how well the vaccine works, continuing with precautions such as mask-wearing and physical distancing will be important.


Myth: COVID-19 vaccines will alter my DNA.


Fact: The COVID-19 vaccines will not alter any human genome and cannot make any changes to your DNA. The vaccines contain all the instructions necessary to teach your cells to make SARS-CoV-2's signature spike protein, release it out into the body, and your immune system gets a practice round at fighting off COVID-19.


Myth: The COVID-19 vaccine can affect women’s fertility


Fact: There is currently no evidence that antibodies formed from COVID-19 vaccination cause any problems with pregnancy, including the development of the placenta. In addition, there is no evidence suggesting that fertility problems are a side effect of any vaccine. People who are trying to become pregnant now or who plan to try in the future may receive the COVID-19 vaccine when it becomes available to them but it’s always prudent to consult with your doctor.


Myth: The COVID-19 vaccine was developed to control the general population either through microchip tracking or "nanotransducers" in our brains.


Fact: There is no vaccine microchip, and the vaccine cannot track people or gather personal information into a database.


Myth: The vaccines were developed and produced using fetal tissue.


Fact: The vaccines do not contain fetal cells nor were fetal cells used in the production the Pfizer and Moderna vaccines. Johnson & Johnson used human cell lines or also known as cell cultures to grow the harmless adenovirus but did not use fetal tissue. These same cell lines have been used for other vaccines including hepatitis, chickenpox and rabies and have been around for years.




Peter Gulick is an associate professor of medicine at Michigan State University, College of Osteopathic Medicine, and serves as adjunct faculty in the College of Human Medicine and the College of Nursing. Dr. Gulick is available to speak with media - simply click on his icon now to arrange an interview today.


Peter Gulick is an associate professor of medicine at Michigan State University, College of Osteopathic Medicine, and serves as adjunct faculty in the College of Human Medicine and the College of Nursing. Dr. Gulick is available to speak with media - simply click on his icon now to arrange an interview today.

Connect with:
Peter Gulick, DO FACP, FIDSA, FACOI

Peter Gulick, DO FACP, FIDSA, FACOI

Professor of Medicine

Take care of HIV/AIDS patients as well as Hepatitis C, B patients at 3 sites in Michigan

Hepatitis CHiv/AidsHepatitis B

You might also like...

Check out some other posts from Michigan State University

5 min

Ask the expert: The constituencies who will determine Michigan’s election results

When it comes to how Michigan has voted in modern presidential elections, a majority of voters have voted for the Democratic nominee for president. In recent years, however, Michigan has become more competitive as a key swing state. In 2016, former President Donald Trump won by just over 10,000 voters and in 2020 President Joe Biden won by just over 150,000 voters. After Vice President Kamala Harris replaced President Biden as the Democratic nominee, she has had a thin lead over Trump and, now, many pundits are saying Michigan is a toss-up. For Harris to win the presidency, she likely must carry Michigan and that includes needed margins with key voter groups such as young voters, as well as Arab American and Black voters. Nazita Lajevardi is an associate professor in the Department of Political Science in the College of Social Science. She is an expert in American politics, and her work focuses mainly on issues related to race and ethnic politics, political behavior, voting rights and immigration. Here, she answers questions on key groups of voters and the issues they care about that could determine who wins Michigan — and likely who will win the presidency. Responses and excerpts are from an article published in Brookings. Where does the election stand in the final days? Since Biden stepped down at the end of July, Harris has enjoyed a steady — albeit at times uncomfortably thin — lead over Trump in Michigan. However, polling from the end of September onward suggests that Harris comfortably winning the state on Nov. 5 is not a foregone conclusion. With just three weeks left to go in the 2024 presidential race, the polling website FiveThirtyEight indicates that as of Oct. 24, 2024, Kamala Harris is ahead of Donald Trump in Michigan by only 0.6 points — 47.6 compared to 47.0. This narrowing of the race appears to be closing the gap that Harris gained over Trump in August. Diving deeper into specific polls feeding into these estimates, it becomes clear that while Harris maintained a solid and consistent lead over Trump by between one and up to eight percentage points in the middle half of September, polls from the third week of September onward have either had Trump leading the state, Harris winning the state by a slim margin, or the two of them being evenly split. What issues do Michigan voters care about? A September 2024 New York Times/Siena College poll found that the three issues Michigan voters cared most about were the economy (24%), abortion (17%) and immigration (14%). Trump, for one, has campaigned heavily in recent weeks about two of these three issues. For instance, he has appealed heavily to Michiganders whose jobs were lost to globalization and automation by promising to revive the American car industry and bring back car factories that have closed in recent years. Groups like Duty to America are highlighting Trump’s strengths on illegal immigration by airing ads across Michigan arguing that it has hurt white people who have been “left behind.” And, while Harris, on the other hand, has great strengths on abortion rights, success in the 2022 elections in amending the state constitution to secure the right to abortion and other reproductive health services may have reduced abortion’s importance as a central voting issue in the state. What impact will Black voters have on Michigan’s result? Among Black voters, experts have identified an enthusiasm gap between those who are part of the “Black leadership class” and deeply connected to the Democratic Party and those Black Michiganders without those same connections, who are more working class, poorer, more fatigued, less interested, and therefore more susceptible to sitting out elections. Many Black voters are also deeply concerned about the economy, and as Michigan State University political scientist Meghan Wilson has noted, Harris could attract Black business owners and holders of student debt by discussing plans to infuse capital into small businesses. The Harris campaign appears to agree. Recently, Harris not only unveiled economic proposals appealing to Black voters but also traveled to Detroit to participate in a radio town hall with Charlamagne tha God, whose program The Breakfast Club has a nationwide audience, much of whom is Black. But attention should be paid to one particular effort to stifle Black turnout. Recently, it was revealed that Tom Barrett, a GOP candidate for the U.S. House, ran a newspaper advertisement in the Black-owned newspaper Michigan Bulletin that incorrectly informed the readership, most of whom are Black, to vote on Nov. 6, when Election Day is Nov. 5. What impact will Arab American voters have on Michigan’s result? Harris is in a deeply precarious position vis-à-vis Michigan’s Muslim and Middle East/North Africa, or MENA, electorates. Without a doubt, these groups will have an outsized impact in deciding how Michigan’s 15 electoral college votes will be cast. According to political scientist Youssef Chouhoud, Michigan is home to more than 200,000 Muslim registered voters. Over the past year, Muslims’ support for the Democratic Party has plummeted. In a recent poll fielded between Aug. 25 and Aug. 27, the Council on American Islamic Relations found that Jill Stein is leading Muslim voters in Michigan; 40% of Muslims surveyed in that poll supported Stein, 18% supported Trump and only 12% supported Harris. And, as Harris’ support for Israel remains steadfast while Israel continues its assaults on Gaza and now Lebanon, she has arguably alienated these voters who could have been a reliable source of electoral support for her. What will the role of youth voters be in Michigan’s outcome? Young voters in Michigan present a potential stream of untapped support for the Democratic Party. Though young voters have historically turned out at lower rates than older Americans, young voters in Michigan stand out from their peers. Fifty-four percent of Michiganders 18 to 29 years old voted in the 2020 election, a 20% increase from 2016. In the 2022 midterms, when young voters aged 18 to 29 in Michigan recorded the highest voter turnout in all the country, they demonstrated how impactful their votes were in enshrining abortion and voting rights in the state constitution. That year, about 75% of students who were registered voters at the University of Michigan and Michigan State University cast ballots. This year, however, how successful Harris has been in activating the youth vote remains to be seen. Certainly, young Michiganders are more enthusiastic about her candidacy than they were Biden’s, but recent analyses by Michigan State University political scientist Corwin Smidt indicate that so far youth turnout in Michigan’s November 2024 election lags behind their 2020 levels. What’s more, young voters were a key part of the “uncommitted” coalition who sent a strong message to then presidential nominee Biden over his enabling of the Israeli war in Gaza during the February 2024 primary election. But Harris is making strides to connect with young voters by establishing offices at campuses across the state. Importantly, young voters could not only shape the outcome of the presidential election, but also the partisan balance in Congress, given that young voters at Michigan State University will have the opportunity to cast a ballot in the race for Michigan’s 7th Congressional District, which is among the 26 toss-up districts in the country. It will be all eyes on Michigan Tuesday - and if you are covering, Nazita Lajevardi is available to help. Simnply click on her profile below to arrange an interview today.

3 min

Ask the Expert: Understand the latest on COVID-19 and mpox

As the university physician at Michigan State, Michael Brown advises the president and other leaders on major health policy or programs that impact life on campus or education abroad programs. He is also chair of the Department of Emergency Medicine in the MSU College of Human Medicine. Here, Brown shares the latest guidance about two viruses that are making news — COVID-19 and mpox, which was formerly called monkeypox. Is COVID-19 changing? COVID-19 will be with us for years to come. It seems to come and go in waves and now, it’s surging again across the United States. We’re seeing more cases, but the number of severe cases is much lower than the peaks we saw during the height of the pandemic. This is good news. Just a small fraction of the people who get COVID-19 actually become sick enough to go to the emergency department. We have to keep that in perspective. How can people stay healthy? The virus does mutate — that’s what viruses do — and a couple recent variants have become predominant. Ideally, the next vaccine will target the latest prevalent variants. I expect the Food and Drug Administration to release a new vaccine very soon, and I definitely will be in line to get one when it’s available. In fact, I highly encourage everyone to get a vaccine this fall. The effectiveness peaks about four weeks after you receive it and lasts at least four to six months — maybe longer. The people who are most protected are those who have had a bout of COVID-19, built up their immunity and received a vaccine. This combination is the best protection from getting an illness that’s severe enough to send you to the hospital. What symptoms are associated with this strain of COVID-19? The symptoms are much like what we’ve seen from COVID-19 in the past. It is an upper respiratory illness, so you may have a sore throat, congestion and a cough, but there can be other symptoms like headache. Some people experience nausea, vomiting or diarrhea. Fever and muscle aches are also common. What if someone tests positive for COVID-19? False positives are very rare with COVID-19 tests so if you get a positive result, you should take care of yourself and protect those around you. The Centers for Disease Control and Prevention recommend that you stay home and wear a mask around others. You should also treat your symptoms, stay hydrated and take acetaminophen for fever and muscle aches. After 24 hours of feeling better and being fever-free (with no acetaminophen), you can go out in public. It’s advised that you wear a mask for an additional five days to protect people who are vulnerable. And what about mpox? Mpox is a viral disease largely found in the Democratic Republic of the Congo in Central Africa. The people there are accustomed to living with it. But it mutates, and we have seen a change in the disease patterns in the past few years. One of the new variants is more severe and is now spreading in the Congo region. It has become a critical situation there, but we have not seen the more severe variant here in the United States. Mpox is not as transmissible as COVID-19 because it requires close contact — usually intimate contact or other close physical proximity like sharing a towel. Symptoms include a rash that may start on the face or genital area along with fever and body aches. A vaccine is available, and an experimental drug can be prescribed as treatment. The World Health Organization has asked developed countries like the United States to assist with research to better understand the new variant. Looking to know more - we can help. Michael Brown is available to speak with media - simply connect with Dalin Clark now to arrange an interview today.

1 min

Just the facts, please

Fact-checking might be a full-time job this election cycle as pundits, people on social media, news panels and even presidential candidates are weighing in on topics - perhaps before getting all the details or double-checking for the truth. With the recent decision by President Biden to opt off the ballot for this November's election - it ignited a firestorm of opinions on whether it was legal or not. It's why places like PolitiFact reached out to Michigan State University's Brian Kalt to get 'the fact's on just what was legal or not. He added however, the the Supreme Court has the final say if it is contested. Brian Kalt, a Michigan State University law professor, said he couldn’t imagine the Supreme Court would prohibit Democrats from replacing Biden as their presidential nominee. "But who can say?" he added. "The Supreme Court has a habit of exceeding the bounds of my imagination." And, if you are a reporter covering politics, the campaigns and the election this November, then let our experts help with your questions and ensure your coverage is accurate. Brian Kalt is a Professor of Law and a Harold Norris Faculty Scholar at Michigan State University. He is an expert in constitutional law of the presidency, and he’s available to speak with media regarding how the Constitution and laws play a role in elections. Simply click on his icon to arrange an interview today.

View all posts
Powered by